CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 90 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-17 | Cummings Keith Lamont Chief Financial Officer | Sale 10b5-1 | −20,148 | $11.20 | $226K | 262,608 |
| 2025-01-17 | Hull Hans Chief Business Officer | Sale 10b5-1 | −15,936 | $11.20 | $179K | 211,558 |
| 2025-01-17 | Lefebvre Eric Chief Medical Officer | Sale 10b5-1 | −18,478 | $11.20 | $207K | 194,574 |
| 2025-01-17 | Cheung Lily Chief Human Resource Officer | Sale 10b5-1 | −3,740 | $11.20 | $42K | 24,550 |
| 2025-01-17 | Ouimette Mike General Counsel & Corp. Sec'y | Sale 10b5-1 | −13,270 | $11.20 | $149K | 80,774 |
| 2024-07-10 | Lefebvre Eric Chief Medical Officer | Sale 10b5-1 | −12,319 | $11.56 | $142K | 213,052 |
| 2024-07-10 | Hull Hans Chief Business Officer | Sale 10b5-1 | −9,900 | $11.56 | $114K | 227,494 |
| 2024-07-10 | Cummings Keith Lamont Chief Financial Officer | Sale 10b5-1 | −10,911 | $11.56 | $126K | 282,115 |
| 2024-07-10 | Coulie Bernard President and CEO | Sale 10b5-1 | −38,710 | $11.56 | $447K | 482,936 |
| 2024-07-10 | Ouimette Mike General Counsel & Corp. Sec'y | Sale 10b5-1 | −7,656 | $11.56 | $89K | 94,044 |
| 2024-07-09 | Lefebvre Eric Chief Medical Officer | Grant or award | +24,063 | 225,371 | ||
| 2024-07-09 | Hull Hans Chief Business Officer | Grant or award | +19,337 | 237,394 | ||
| 2024-07-09 | Cummings Keith Lamont Chief Financial Officer | Grant or award | +21,313 | 293,026 | ||
| 2024-07-09 | Coulie Bernard President and CEO | Grant or award | +75,625 | 521,646 | ||
| 2024-07-09 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award | +14,954 | 101,700 | ||
| 2024-06-13 | MCCOURT Thomas A Director | Grant or award · Common Stock (Right to Buy) | +26,764 | 26,764 | ||
| 2024-06-13 | Knobil Katharine Director | Grant or award · Common Stock (Right to Buy) | +26,764 | 26,764 | ||
| 2024-06-13 | Huh Hoyoung Director | Grant or award · Common Stock (Right to Buy) | +26,764 | 26,764 | ||
| 2024-06-13 | PYOTT DAVID E I Director | Grant or award · Common Stock (Right to Buy) | +26,764 | 26,764 | ||
| 2024-06-13 | Shah Smital Director | Grant or award · Common Stock (Right to Buy) | +26,764 | 26,764 |
Page 5 of 8 · 160 trades